Leading Growth Driver in the Autism Spectrum Disorder Diagnostics Market in 2025: Growth In Specialized Diagnostic Centers Drives Expansion Of Autism Spectrum Disorders Diagnostic Market Driver's Influence

What combination of drivers is leading to accelerated growth in the autism spectrum disorder diagnostics market?
The surge in specialized diagnostic centers is projected to boost the autism spectrum disorders diagnostic market in the future. Specialized centers for diagnosing autism are equipped with medical professionals, psychologists, and experts who perform thorough evaluations for diagnosing autism spectrum disorder. The expansion of these specialized centers can be attributed to advancements in diagnosis, the demand for integrated care, specialist training, research, and the recognition of autism as a significant public health concern. These diagnostic centers are essential in enhancing diagnostic precision, promoting early interventions, and improving the results for persons with ASD by offering distinguished expertise, sophisticated diagnostic instruments, comprehensive evaluations, personalized treatment plans, familial support, and research collaboration possibilities. For example, Autism Speaks, a non-profit organization for autism awareness based in the US, reported that the number of autism care network sites grew from 20 to 25 between 2021 and 2022 in North America. Hence, the rise in specialized diagnostic centers is propelling the growth of the autism spectrum disorders diagnostic market.

Get Your Autism Spectrum Disorder Diagnostics Market Report Here:
https://www.thebusinessresearchcompany.com/report/autism-spectrum-disorder-diagnostics-global-market-report

What is the projected compound annual growth rate (CAGR) of the autism spectrum disorder diagnostics market from 2025 to 2034, and what factors influence it?
The market size for autism spectrum disorder diagnosis has seen a robust growth in recent times. It will expand from $27.39 billion in 2024, escalating to $29.44 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.5%. The expansion during the historic period can be linked to the rising awareness and recognition of ASD, expansion of diagnostic criteria, progression in diagnostic tools, enhancement in healthcare systems, and public health campaigns.

It is projected that the market size of autism spectrum disorder diagnostics will experience robust growth in the coming years. The market is expected to reach $38.94 billion by 2029, with a 7.2% compound annual growth rate (CAGR). The predicted growth during this period is attributed to a rise in the occurrence of autism spectrum disorder, increased awareness and early diagnosis programs, a concentration on precision medicine and biomarkers. Major future trends include continuous development of novel technologies, rising attention towards adults diagnosis, growing demand for immediate point-of-care testing, the inclusion of artificial intelligence (AI) and machine learning, as well as an upsurge in research activities.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16593&type=smp

What are the emerging trends shaping the future of the autism spectrum disorder diagnostics market?
Leading firms in the autism spectrum disorder diagnostics market are innovating with advanced strategies, such as employing devices that make use of Dynamic Quantification of Social-Visual Engagement (DQSVE), to secure a competitive advantage. This technique records and scrutinizes a child's gaze pattern at a frequency of 120 instances per second. For example, the Marcus Autism Center, a nonprofit healthcare and research institution based in the US, introduced the EarliPointTM Evaluation in September 2023. This revolutionary FDA-approved device is engineered for the early detection of autism spectrum disorder (ASD) in children from 16 to 30 months old. The device leverages eye-tracking technology to evaluate children's social interactions, drastically cutting the diagnosis time from several hours to roughly 12 minutes.

What are the major segments of the autism spectrum disorder diagnostics market and their role in driving growth?
The autism spectrum disorder diagnostics market covered in this report is segmented -

1) By Type: Autistic Disorder, Asperger Syndrome, Pervasive Development Disorder (PDD), Other Types
2) By Service: Behavioral Approaches, Early Intervention, Medication, Other Services
3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Autistic Disorder: Classic Autism, Severe Autism, Mild Autism
2) By Asperger Syndrome: High Functioning Asperger Syndrome, Low Functioning Asperger Syndrome
3) By Pervasive Developmental Disorder (PDD): PDD-NOS, Childhood Disintegrative Disorder: Rett Syndrome
4) By Other Types: Childhood Autism Spectrum Disorder, Atypical Autism, Other Related Developmental Disorders

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16593

Which regions are key players in the growth of the autism spectrum disorder diagnostics market?
Asia-Pacific was the largest region in the autism spectrum disorder diagnostics market in 2024. The regions covered in the autism spectrum disorder diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the autism spectrum disorder diagnostics market?
Major companies operating in the autism spectrum disorder diagnostics market are F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Siemens Healthineers, Quest Diagnostics Incorporated, Agilent Technologies Inc., Otsuka Pharmaceutical Co. Ltd., ARUP Laboratories, Invitae Corporation, Ambry Genetics, Cortica Inc., GeneDx, Cognoa Inc., Axial Therapeutics Inc., Curemark, EarliTec Diagnostics Inc., Yamo Pharmaceuticals

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=16593&type=smp

What Is Covered In The Autism Spectrum Disorder Diagnostics Global Market Report?

•Market Size Forecast: Examine the autism spectrum disorder diagnostics market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the autism spectrum disorder diagnostics market for a structured understanding.
•Key Players Overview: Analyze major players in the autism spectrum disorder diagnostics market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the autism spectrum disorder diagnostics market.
•Segment Contributions: Evaluate how different segments drive overall growth in the autism spectrum disorder diagnostics market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the autism spectrum disorder diagnostics market.
•Industry Challenges: Identify potential risks and obstacles affecting the autism spectrum disorder diagnostics market.
•Competitive Landscape: Review strategic developments in the autism spectrum disorder diagnostics market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.